Unicycive Therapeutics Inc (UNCY) Implied Volatility Current

Tracking UNCY implied volatility helps you identify when options premiums on Unicycive Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Unicycive Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when UNCY IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Unicycive Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For UNCY, tracking metrics like UNCY IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on UNCY signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where UNCY implied volatility sits today versus where it has been. Our scanner ranks Unicycive Therapeutics Inc implied volatility against its historical range, surfaces extremes in UNCY IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Unicycive Therapeutics Inc IV is rich or cheap — measure it, then act on it.